Nathan Lyman is an experienced market access professional currently serving as the Market Access Lead for the Chronic Disease Portfolio at Genentech since 2019. Lyman specializes in market access insights, contracting profitability analytics, and payer/provider strategy across various therapeutic areas including Neurology, Immunology, Respiratory, and Ophthalmology. Previously held roles at Genentech include Product Innovation & Enablement Lead, where design and implementation of advanced analytic tools enhanced decision-making processes. Lyman also served as a Strategic Analytics & Intelligence Senior Manager, contributing strategic intelligence to guide decision-making. Prior experience includes consulting roles at Huron and Promidian, along with an internship at Roche Diagnostics and early-stage experience with the National Institutes of Health. Lyman holds a Master of Bioscience in Business of Bioscience from Keck Graduate Institute and a B.S. in Chemistry from the University of Maryland.
This person is not in any teams
This person is not in any offices